New oral diabetes drug orforglipron (Foundayo) proves heart-safe in study, meeting cardiovascular safety standards compared to insulin glargine.
Medtronic ships new insulin pump with sensor, offering smallest app-controlled pump and world’s smallest sensor for up to 15 days use.